Picture of Sharps Technology logo

STSS Sharps Technology Share Price

0.000.00%
us flag iconLast trade - 00:00
HealthcareSpeculativeMicro CapValue Trap

Momentum

Relative Strength (%)
1m-87.85%
3m-98.67%
6m-99.22%
1yr-99.7%
Volume Change (%)
10d/3m+283.94%
Price vs... (%)
52w High-99.89%
50d MA-89.63%
200d MA-99.25%

Growth & Value

Shareholder Activity

TypeBuy / Hold / Sell
Institutions
Directors
Community

Guru Screens

Quality

NameIndustryMarket
Return on Capital-452.38%
Return on Equity-187.23%
Operating Marginn/a

Health Trend(F-Score)

12345678910

Bankruptcy Score(Z-Score)

Distress
Cautious
Safe

Earnings Manipulation Risk(M-Score)

Other Ratios

Leverage (ttm)Total- Intang+ Pension
Gross Gearing
Net Gearing
Cash / Assets

Recent History

Latest interim period vs. prior periodIndustryMarket
Sales Growth
EPS Growth
3yr Compound Annual Growth RateIndustryMarket
Sales CAGR
EPS CAGR
DPS CAGR

Graphical History

Revenue
Blurred out image of Revenue chart
Net Income
Blurred out image of Net Income chart
Normalised EPS
Blurred out image of Normalised EPS chart
PE Ratio Range
Blurred out image of PE Ratio Range chart
Dividend Yield Range
Blurred out image of Dividend Yield Range chart

Analyst Forecasts

Price target
( price)
31st Dec 202531st Dec 2026
Est. Long Term Growth Rate: Net Profit
()
EPS
()
DPS
()
Net Profit
()
EPS
()
DPS
()
Consensus Estimate
1m Change
3m Change

Analyst Consensus

Strong SellSellHoldBuyStrong Buy

EPS 2025 / 2026

Blurred out image of Sharps Technology EPS forecast chart

Profile Summary

Sharps Technology, Inc. is a medical device and pharmaceutical packaging company. The Company is engaged in offering patented smart-safety syringe products to the healthcare industry. The Company's smart safety syringe products, such as Securgard, Sologard, and Sharps Provensa, are ultra-low waste syringes that incorporate both passive and active safety and reuse prevention features. It Sharps Securegard and Sologard safety syringe product lines incorporate both active and passive safety features and have been designed to address the primary administration concerns with syringe delivery systems, including accidental needlestick injuries, wasted medicine/dead space and reuse prevention. It also offers products that are designed with specialized copolymer technology to support the prefillable syringe market segment. It has a manufacturing facility in Hungary and is pursuing plans to expand its manufacturing capacity in the United States.

Directors

    Last Annual
    December 31st, 2024
    Last Interim
    December 31st, 2024
    Incorporated
    March 16th, 2022
    Public Since
    April 14th, 2022
    No. of Shareholders
    142
    No. of Employees
    5
    Sector
    Healthcare Equipment & Supplies
    Industry
    Healthcare
    Exchange
    us flag iconNASDAQ Capital Market
    Shares in Issue
    16,333,897

    STSS Share Price Performance

    Similar to STSS

    Picture of Accelerate Diagnostics logo

    Accelerate Diagnostics

    us flag iconNASDAQ Capital Market

    Picture of Adagio Medical Holdings logo

    Adagio Medical Holdings

    us flag iconNASDAQ Capital Market

    Picture of Adapthealth logo

    Adapthealth

    us flag iconNASDAQ Capital Market

    Picture of Aethlon Medical logo

    Aethlon Medical

    us flag iconNASDAQ Capital Market

    Picture of Agape ATP logo

    Agape ATP

    us flag iconNASDAQ Capital Market

    FAQ